SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 311,163.56 |
| Enterprise Value ($M) | 385,522.56 |
| Book Value ($M) | 10,397.00 |
| Book Value / Share | 5.89 |
| Price / Book | 29.93 |
| NCAV ($M) | -101,956.00 |
| NCAV / Share | -57.74 |
| Price / NCAV | -3.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.07 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.83 |
| Current Ratio | 0.94 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 38,871.00 |
| Assets | 148,874.00 |
| Liabilities | 140,827.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54,318.00 |
| Operating Income | 17,425.00 |
| Net Income | 4,863.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 22,839.00 |
| Cash from Investing | -2,009.00 |
| Cash from Financing | -17,222.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.08 | 1.30 | |
| 13G/A | BlackRock Inc. | 8.10 | 3.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,238,373 | 5,346,471 | 23.16 | |
| 2,202,737 | 7,788,395 | 28.28 | |
| 970,771 | 4,027,343 | 24.10 | |
| 542,463 | 2,090,527 | 25.95 | |
| 539,030 | 2,595,196 | 20.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABT – Abbott Laboratories | ADCT – ADC Therapeutics SA |